Non-enzymatic glycation of proteins: from diabetes to cancer
Biomeditsinskaya Khimiya · 2010
DOI: 10.18097/pbmc20105602168 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomeditsinskaya Khimiya, 2010. Verfasst von N A Ansari und 1 weiteren Autor:innen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Incubation of proteins with glucose leads to their non-enzymatic glycation and formation of Amadori products known as an early glycation product. Oxidative cleavage of Amadori products is considered as a major route to advanced glycation endproducts (AGEs) formation in vivo. Nonenzymatic glycation of proteins or Maillard reaction is increased in diabetes mellitus due to hyperglycemia and leads to several complications such as blindness, heart disease, nerve damage and kidney failure. Accumulation of the early and advanced glycation products in plasma and tissues of diabetic patients and causes production of autoantibodies against corresponding products. The advanced glycation products are also associated with other diseases like cancer. This review summarizes current knowledge of these stage specific glycated products as common and early diagnostic biomarkers for the associated diseases and the complications with the aim of a novel therapeutic target for the diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Ansari, N. A., & Rasheed, Z. (2010). Non-enzymatic glycation of proteins: from diabetes to cancer. Biomeditsinskaya Khimiya. https://doi.org/10.18097/pbmc20105602168
Vancouver
Ansari NA, Rasheed Z. Non-enzymatic glycation of proteins: from diabetes to cancer. Biomeditsinskaya Khimiya. 2010. doi:10.18097/pbmc20105602168
BibTeX
@article{Ansari2010,
author = {Ansari, N A and Rasheed, Z},
title = {Non-enzymatic glycation of proteins: from diabetes to cancer},
journal = {Biomeditsinskaya Khimiya},
year = {2010},
doi = {10.18097/pbmc20105602168}
}
EUVIMED